1. Home
  2. HAE vs CPRI Comparison

HAE vs CPRI Comparison

Compare HAE & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.16

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Capri Holdings Limited

CPRI

Capri Holdings Limited

HOLD

Current Price

$17.78

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAE
CPRI
Founded
1971
1981
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
HAE
CPRI
Price
$59.16
$17.78
Analyst Decision
Buy
Buy
Analyst Count
9
13
Target Price
$84.13
$26.62
AVG Volume (30 Days)
758.2K
2.2M
Earning Date
05-07-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
44.54
N/A
EPS
2.46
1.18
Revenue
$910,373,000.00
$4,442,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.23
$1.81
P/E Ratio
$23.14
$14.48
Revenue Growth
N/A
N/A
52 Week Low
$47.32
$16.49
52 Week High
$87.32
$28.27

Technical Indicators

Market Signals
Indicator
HAE
CPRI
Relative Strength Index (RSI) 55.46 42.67
Support Level $49.26 $16.82
Resistance Level $62.48 $22.14
Average True Range (ATR) 3.21 0.74
MACD 0.38 -0.14
Stochastic Oscillator 85.46 31.11

Price Performance

Historical Comparison
HAE
CPRI

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About CPRI Capri Holdings Limited

Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.

Share on Social Networks: